Inducible and reversible RNA N<sup>6</sup>-methyladenosine editing.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 35414049.
- Also identified by DOI 10.1038/s41467-022-29665-y and PMC identifier 9005610.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
RNA modifications, including N<sup>6</sup>-methyladenosine (m<sup>6</sup>A), have been reported to regulate fundamental RNA processes and properties, and directly linked to various human diseases. Methods enabling temporal and transcript/locus-specific editing of specific RNA modifications are essential, but still limited, to dissect the dynamic and context-dependent functions of these epigenetic modifications. Here, we develop a chemically inducible and reversible RNA m<sup>6</sup>A modification editing platform integrating chemically induced proximity (CIP) and CRISPR methods. We show that m<sup>6</sup>A editing can be temporally controlled at specific sites of individual RNA transcripts by the addition or removal of the CIP inducer, abscisic acid (ABA), in the system. By incorporating a photo-caged ABA, a light-controlled version of m<sup>6</sup>A editing platform can be developed. We expect that this platform and strategy can be generally applied to edit other RNA modifications in addition to m<sup>6</sup>A.
Medical subject headings
- CRISPR-Cas Systems
- RNA